IL-33 Gene Polymorphisms as Potential Biomarkers of Disease Susceptibility and Response to TNF Inhibitors in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients.

Iwaszko M, Wielińska J, Świerkot J, Kolossa K, Sokolik R, Bugaj B, Chaszczewska-Markowska M, Jeka S, Bogunia-Kubik K

Open source

DOI
10.3389/fimmu.2021.631603
Published
2021
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2021.631603,
  title = {IL-33 Gene Polymorphisms as Potential Biomarkers of Disease Susceptibility and Response to TNF Inhibitors in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients.},
  author = {Iwaszko M and Wielińska J and Świerkot J and Kolossa K and Sokolik R and Bugaj B and Chaszczewska-Markowska M and Jeka S and Bogunia-Kubik K},
  year = {2021},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2021.631603},
  url = {https://doi.org/10.3389/fimmu.2021.631603}
}

RIS

TY  - JOUR
TI  - IL-33 Gene Polymorphisms as Potential Biomarkers of Disease Susceptibility and Response to TNF Inhibitors in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients.
AU  - Iwaszko M
AU  - Wielińska J
AU  - Świerkot J
AU  - Kolossa K
AU  - Sokolik R
AU  - Bugaj B
AU  - Chaszczewska-Markowska M
AU  - Jeka S
AU  - Bogunia-Kubik K
PY  - 2021
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2021.631603
UR  - https://doi.org/10.3389/fimmu.2021.631603
ER  - 

APA

M, I., J, W., J, Ś., K, K., R, S., B, B., M, C., S, J., & K, B. (2021). IL-33 Gene Polymorphisms as Potential Biomarkers of Disease Susceptibility and Response to TNF Inhibitors in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2021.631603

Source records